SCD Depo
Brief description of study
The Women's Health Clinical Research Center at Penn Medicine is conducting a paid research study to see if women with sickle cell disease (SCD) experience any pain differences while using the birth control injection known as Depo, as compared to when not using it. Depo-Provera is already FDA-approved, safe to use, and lasts for 3 months.
The study duration is 6 months, with 6-7 in-person visits that include a urine pregnancy test, blood draw, and surveys. Participants will also complete weekly surveys asking about pain and their menstrual cycle, and will be compensated up to $715 for completing all parts of the study. In-person visits will be conducted at 3737 Market Street, Philadelphia, PA.
We are seeking women who are between the ages of 18 and 50 who have been diagnosed with SCD, have a regular menstrual cycle, and experience at least one vaso-occlusive pain episode per month.
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Sickle Cell Disease, SCD
-
Age: 18 years - 50 years
-
Gender: Female
Seeking participants who are/have:
- Female, aged 18-50 years old
- Diagnosis of sickle cell disease (SS, SB0,SB+,SC)
- Report of at least 1 vaso-occlusive pain episode per month on average in the previous 6 months
- Willing to discontinue any hormonal contraception at the time of enrollment.
- Have regular menstrual cycles (when not on hormonal contraception) with a usual length of 21 to 35 days.
Find a site
,
Send a message
Enter your contact details to connect with study team
Primary Contact
Interested in the study
Select a study center that’s convenient for you, and get in touch with the study team.
Contact a study centerPlease choose between Voice or SMS based delivery of verification code
or